Über das Unternehmen

ProAlt is young biotech company developing innovative products for colorectal cancer early diagnosis in blood and novel therapeutic antibodies for the treatment of colon, breast and melanoma metastatic tumors. The company also offers its own manufactured recombinant proteins and antibodies, and different custom-tailored services in protein and antibodies design and manufacturing (CRO/CMO).

ES
Nicht verifiziertes Unternehmen